CoChat

Female mouse fetal loss mediated by maternal autoantibody

Open access

The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.

Abstract

Systemic lupus erythematosus (SLE), a disease of women during childbearing years, is characterized by the production of double-stranded DNA antibodies. A subset of these antibodies, present in 40% of patients, cross-reacts with the NR2A and NR2B subunits of the N-methyl-d-aspartate receptor (NMDAR). In this study, we show that, in mouse models, these antibodies cause a loss of female fetus viability by inducing apoptosis of NR2A-expressing neurons within the brainstem late in fetal development; gender specificity derives from a time-dependent increased expression of NR2A in female brainstem or increased vulnerability of female fetal neurons to signaling through NR2A-containing NMDARs. This paradigm is consistent with available data on the sex ratio of live births of women with SLE. It represents a novel mechanism by which maternal autoantibodies can severely affect fetal health in a gender-specific fashion and raises the question of how many maternal antibodies affect brain development or exhibit gender-specific fetal effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20111986

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Female to male (F/M) ratio in offspring of lupus mice. (A) PCR of Sry DNA was used to identify male fetuses, with Myogenin acting as control for the integrity of DNA. (B) Gonads were stained with cresyl violet (stains cell bodies) for histological analysis. Bar, 50 µm. (C, left) Graph showing the percentage of male and female offspring born of MP (mice immunized with a peptide mimetope of DNA [DWEYSVWLSN] multimerized on a poly-lysine backbone)-, MC (mice immunized with a poly-lysine backbone alone)-, or MS (mice immunized with a scrambled peptide [WSDYEVWLSN] on a poly-lysine backbone)-immunized dams and WT dams. Number of offspring is indicated in each column. (right) F/M ratio per litter (mean ± SEM). Ratios for offspring of mice born to dams given DNRAb R4A or control IgG2b intravenously on day E13 are also shown. (D, left) The graph shows serum binding to DWEYS and double-stranded DNA (dsDNA) in young (<16 wk) and old (>25 wk) triple congenic Sle1,2,3 mice (a model of SLE; mean ± SEM). (middle) F/M ratio per litter of Sle1,2,3 mice. (right) Graph showing the F/M ratio in offspring of young and old Sle1,2,3 mice (mean ± SEM). (E) Fetuses were obtained on day E12–E15 or E17–E19. The percentage of intact male and female fetuses is shown with actual numbers within each column of the graph. (F) F/M ratios per litter (mean ± SEM). (G) Concentration of IgG in the fetal brain. Cohort sizes, 21–85 fetuses, are indicated in each column. *, P < 0.05; **, P < 0.01; ***, P < 0.001, ANOVA. Data are representative of two independent experiments.
Figure 1. Female to male (F/M) ratio in offspring of lupus mice. (A) PCR of Sry DNA was used to identify male fetuses, with Myogenin acting as control for the integrity of DNA. (B) Gonads were stained with cresyl violet (stains cell bodies) for histological analysis. Bar, 50 µm. (C, left) Graph showing the percentage of male and female offspring born of MP (mice immunized with a peptide mimetope of DNA [DWEYSVWLSN] multimerized on a poly-lysine backbone)-, MC (mice immunized with a poly-lysine backbone alone)-, or MS (mice immunized with a scrambled peptide [WSDYEVWLSN] on a poly-lysine backbone)-immunized dams and WT dams. Number of offspring is indicated in each column. (right) F/M ratio per litter (mean ± SEM). Ratios for offspring of mice born to dams given DNRAb R4A or control IgG2b intravenously on day E13 are also shown. (D, left) The graph shows serum binding to DWEYS and double-stranded DNA (dsDNA) in young (<16 wk) and old (>25 wk) triple congenic Sle1,2,3 mice (a model of SLE; mean ± SEM). (middle) F/M ratio per litter of Sle1,2,3 mice. (right) Graph showing the F/M ratio in offspring of young and old Sle1,2,3 mice (mean ± SEM). (E) Fetuses were obtained on day E12–E15 or E17–E19. The percentage of intact male and female fetuses is shown with actual numbers within each column of the graph. (F) F/M ratios per litter (mean ± SEM). (G) Concentration of IgG in the fetal brain. Cohort sizes, 21–85 fetuses, are indicated in each column. *, P < 0.05; **, P < 0.01; ***, P < 0.001, ANOVA. Data are representative of two independent experiments.CC BY-NC-SA · PubMed Central
Figure 2. Neuronal death in fetal brains. (A, left) Sagittal whole-brain section (Nissl stained) of female fetus at E17. The boxes highlight the PN and RFP. (right) Representative magnified PN and RFP sections. (B) PN sections labeled for activated caspase-3 (C3+) in fetuses from MP- and MC-immunized dams. Bars: (A) 500 µm; (B) 50 µm. (C–F) Graphs show C3+ cells (mean ± SEM) counted in comparable regions (volume, 1.2 × 106 µm3) of the PN and RFP in the fetal brain. (C) Cell counts from MP and MC fetuses. Data are representative of three experiments. (D) Ex vivo brainstem slices from E17 fetuses were exposed to 100 µg/ml R4A or 100 µg/ml IgG2b for 12 h, fixed, and stained for C3+ reactivity. (E) Slices were treated with 200 µg/ml of purified serum DNARAbs (MP-Ab) or 200 µg/ml of mouse IgG (MC-Ab). (F) Slices were exposed to 400 µg/ml of human DNRAbs (Hu-Ab) or 400 µg/ml of human IgG (Hu-C). Sample sizes, 10–15 sections per column from three to four litters. *, P < 0.05; **, P < 0.01; ***, P < 0.001, ANOVA. Data are representative of two independent experiments.
Figure 2. Neuronal death in fetal brains. (A, left) Sagittal whole-brain section (Nissl stained) of female fetus at E17. The boxes highlight the PN and RFP. (right) Representative magnified PN and RFP sections. (B) PN sections labeled for activated caspase-3 (C3+) in fetuses from MP- and MC-immunized dams. Bars: (A) 500 µm; (B) 50 µm. (C–F) Graphs show C3+ cells (mean ± SEM) counted in comparable regions (volume, 1.2 × 106 µm3) of the PN and RFP in the fetal brain. (C) Cell counts from MP and MC fetuses. Data are representative of three experiments. (D) Ex vivo brainstem slices from E17 fetuses were exposed to 100 µg/ml R4A or 100 µg/ml IgG2b for 12 h, fixed, and stained for C3+ reactivity. (E) Slices were treated with 200 µg/ml of purified serum DNARAbs (MP-Ab) or 200 µg/ml of mouse IgG (MC-Ab). (F) Slices were exposed to 400 µg/ml of human DNRAbs (Hu-Ab) or 400 µg/ml of human IgG (Hu-C). Sample sizes, 10–15 sections per column from three to four litters. *, P < 0.05; **, P < 0.01; ***, P < 0.001, ANOVA. Data are representative of two independent experiments.CC BY-NC-SA · PubMed Central
Figure 3. Expression of messenger RNA for NMDAR subunits NR1, NR2A, and NR2B in fetal brain. Graphs show the level of messenger RNA transcript (mean ± SEM) for each subunit, divided by the level of polymerase 2a (P2a). (A and B) Male and female fetuses of WT mice were harvested at E15 (A) or E17 (B), and qPCR was used to assess transcripts of NR1 (left), NR2A (middle), and NR2B (right) in brainstem and cortex. Sample size, 12–15 fetuses per column. *, P < 0.05; **, P < 0.01, Student’s t test. Data show a representative experiment from three independent experiments. (C, left and middle) R4A or control IgG2b staining of WT or NR2A−/− fetal brain. (right) R4A or control IgG2b staining of WT or NR2A−/− adult hippocampus. Bars: (left and middle) 50 µm; (right) 100 µm. (D) R4A triggers an enhancement in the amplitude of excitatory postsynaptic potentials (EPSP), mediated by NMDARs, in NR2A−/− hippocampus. The gray box marks the period of antibody application. (right) Representative traces obtained immediately after treatment with R4A (i) or IgG2b control (ii). Representative data from three independent experiments are shown.
Figure 3. Expression of messenger RNA for NMDAR subunits NR1, NR2A, and NR2B in fetal brain. Graphs show the level of messenger RNA transcript (mean ± SEM) for each subunit, divided by the level of polymerase 2a (P2a). (A and B) Male and female fetuses of WT mice were harvested at E15 (A) or E17 (B), and qPCR was used to assess transcripts of NR1 (left), NR2A (middle), and NR2B (right) in brainstem and cortex. Sample size, 12–15 fetuses per column. *, P < 0.05; **, P < 0.01, Student’s t test. Data show a representative experiment from three independent experiments. (C, left and middle) R4A or control IgG2b staining of WT or NR2A−/− fetal brain. (right) R4A or control IgG2b staining of WT or NR2A−/− adult hippocampus. Bars: (left and middle) 50 µm; (right) 100 µm. (D) R4A triggers an enhancement in the amplitude of excitatory postsynaptic potentials (EPSP), mediated by NMDARs, in NR2A−/− hippocampus. The gray box marks the period of antibody application. (right) Representative traces obtained immediately after treatment with R4A (i) or IgG2b control (ii). Representative data from three independent experiments are shown.CC BY-NC-SA · PubMed Central
Figure 4. Lack of fetal death in NR2A−/− mice. (A, left) Graph shows the percentage of male and female offspring from MP- or MC-immunized NR2A−/− (KO) dams and offspring of NR2A+/− dams and NR2A−/− males, with offspring numbers indicated in each column. (right) F/M ratios per litter (mean ± SEM) in MP- and MC-immunized mice. (B and C) Ex vivo brainstem slices (E17) were prepared from KO and WT fetuses, exposed to 100 µg/ml R4A or 100 µg/ml IgG2b for 12 h, fixed, and labeled for activated caspase-3 (C3+). The graphs show C3+ cells (mean ± SEM) in the PN (B) and RFP (C; volume, 1.2 × 106 µm3) for female (left) and male (right) fetuses. Sample sizes, 10 sections per column from two to four litters. ***, P < 0.001, ANOVA. Data are representative of three experiments. (D, left) Representative fluorescent micrographs of neurons in the hippocampus in acute slices from KO and WT mice, before (T0) and after (T4) treatment with NMDA and R4A; T0, onset of insult, T40, 40 min after insult (green, calcein; blue, DAPI). Loss of calcein fluorescence indicates increased mitochondrial stress. Bar, 10 µm. (middle) Profile of fluorescence decay in controls and R4A-treated groups (KO and WT). The gray box at T40 highlights the comparison shown at the right where fluorescence levels at T40 are expressed as percent change from control for adult and fetal slices (mean ± SEM). *, P < 0.05, Student’s t test. (E and F) Graphs show the level of messenger RNA transcript (mean ± SEM) for NR1 and NR2B subunits, divided by the level of polymerase 2a (P2a), from KO mice. Male and female fetuses were harvested at E15 (E) and E17 (F), and qPCR was used to assess transcripts of NR1, NR2A, and NR2B in brainstem and cortex. The level of NR2A transcript was zero in both age groups. *, P < 0.05. Data are representative of four experiments.
Figure 4. Lack of fetal death in NR2A−/− mice. (A, left) Graph shows the percentage of male and female offspring from MP- or MC-immunized NR2A−/− (KO) dams and offspring of NR2A+/− dams and NR2A−/− males, with offspring numbers indicated in each column. (right) F/M ratios per litter (mean ± SEM) in MP- and MC-immunized mice. (B and C) Ex vivo brainstem slices (E17) were prepared from KO and WT fetuses, exposed to 100 µg/ml R4A or 100 µg/ml IgG2b for 12 h, fixed, and labeled for activated caspase-3 (C3+). The graphs show C3+ cells (mean ± SEM) in the PN (B) and RFP (C; volume, 1.2 × 106 µm3) for female (left) and male (right) fetuses. Sample sizes, 10 sections per column from two to four litters. ***, P < 0.001, ANOVA. Data are representative of three experiments. (D, left) Representative fluorescent micrographs of neurons in the hippocampus in acute slices from KO and WT mice, before (T0) and after (T4) treatment with NMDA and R4A; T0, onset of insult, T40, 40 min after insult (green, calcein; blue, DAPI). Loss of calcein fluorescence indicates increased mitochondrial stress. Bar, 10 µm. (middle) Profile of fluorescence decay in controls and R4A-treated groups (KO and WT). The gray box at T40 highlights the comparison shown at the right where fluorescence levels at T40 are expressed as percent change from control for adult and fetal slices (mean ± SEM). *, P < 0.05, Student’s t test. (E and F) Graphs show the level of messenger RNA transcript (mean ± SEM) for NR1 and NR2B subunits, divided by the level of polymerase 2a (P2a), from KO mice. Male and female fetuses were harvested at E15 (E) and E17 (F), and qPCR was used to assess transcripts of NR1, NR2A, and NR2B in brainstem and cortex. The level of NR2A transcript was zero in both age groups. *, P < 0.05. Data are representative of four experiments.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 45

Metadata

Authors
Wang, L., Zhou, D., Lee, J., Niu, H., Faust, T. W., Frattini, S., Kowal, C., Huerta, P. T., Volpe, B. T., & Diamond, B.
Affiliations
  • Northwell Health (US)
  • Massachusetts General Hospital (US)
Corresponding author
Diamond, Betty
Venue
Journal of Experimental Medicine
Published
2012-05-07
Volume
209
Issue
6
Pages
1083-1089
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2016329099
Cited by
44
References
28
Citations by year
2024: 1 · 2023: 2 · 2022: 3 · 2021: 4 · 2020: 1 · 2019: 4 · 2018: 2 · 2017: 4 · 2016: 6 · 2015: 5 · 2014: 3 · 2013: 5 · 2012: 4
FWCI
4.17
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Funders
National Institute of Allergy and Infectious Diseases (P01AI073693)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
  • Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
Keywords
systemic lupus erythematosus, maternal autoantibodies, fetal death, NMDA receptor, NR2A subunit, NR2B subunit, anti-dsDNA antibodies, brainstem neurons, neuronal apoptosis, sex differences, fetal brain development, mouse model
MeSH terms
Animals, Animals, Newborn, Antibodies, Antinuclear, Autoantibodies, Brain, Female, Fetal Death, Humans, Lupus Erythematosus, Systemic, Male, Mice, Inbred BALB C, Neurons, Oligopeptides, Pregnancy, Sex Factors, Sex Ratio, Receptors, N-Methyl-D-Aspartate, Apoptosis, Gene Expression Regulation, Developmental, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Female mouse fetal loss mediated by maternal autoantibody. https://app.cochat.ai/papers/10.1084/jem.20111986
The paper
Wang, L., Zhou, D., Lee, J., Niu, H., Faust, T. W., Frattini, S., Kowal, C., Huerta, P. T., Volpe, B. T., & Diamond, B. (2012). Female mouse fetal loss mediated by maternal autoantibody. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20111986

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.